
Investment17 Jun 2026, 11:31 am
Chemkart Invests ₹1 Cr in Subsidiary via Rights Issue
AI Summary
Chemkart India Ltd has invested ₹1.00 Crores in its wholly-owned subsidiary, Easy Raw Materials Private Limited, through a rights issue. This investment, comprising 10,00,000 equity shares at face value, is part of the utilization of IPO proceeds to commission the subsidiary's manufacturing unit. Easy Raw Materials Private Limited is involved in trading pharma products and nutritional supplements. The subsidiary reported NIL turnover, a loss after tax of ₹59.47 Lakhs, and a net worth of ₹578.60 Lakhs as of March 31, 2026. Chemkart's shareholding in the subsidiary remains at 100%.
Key Highlights
- Chemkart invested ₹1 Cr in subsidiary Easy Raw Materials via rights issue.
- Investment aims to commission subsidiary's manufacturing unit.
- Subsidiary trades pharma products and nutritional supplements.
- Chemkart's stake in subsidiary remains 100% post-investment.
Price Impact
More from CHEMKART